JUNE 24 - 26, 2021 / WORLDWIDE
Group schema therapy has a strong evidence base for chronic psychiatric conditions. The aim of this study was to:
1) explore group schema therapy for persistent depression
2) compare the program delivery format: face to face versus telehealth to assess the feasibility of telehealth delivery
Based on Farrell and Shaws (2012) Group Schema Therapy Protocol, a 20 week group program was delivered in face-to-face format in 2019, and via telehealth in 2020/21.
This presentation presents quantitative and qualitative results that explore the feasibility of conducting group schema therapy via telehealth. Findings are discussed, including clinical implications and the need for future research.
About the Presenters
Dr Younan is the director and founder of the Schema Therapy Institute Australia. Dr Younan works both in Individual and Group Schema Therapy and was the Director of The Schema Therapy Department at The Victoria Clinic, a private psychiatric hospital in Melbourne, Australia. In collaborating with the founders of Group Schema Therapy, Professor Joan Farrell & Ms Ida Shaw, Dr Younan developed an intensive 4-week inpatient program in Group Schema Therapy for Complex Trauma and subsequent outpatient program.
Dr Younan has been provided with permission to empirically assess the feasibility and efficacy of this treatment program and recently presented the data as part of a Schema Therapy Panel at the 8th World Congress of Behavioural and Cognitive Therapies. Dr Younan was invited to present this data in Vienna, Austria at the International Conference for Schema Therapy as part of a panel devoted to Group Schema Therapy.
Dr. Younan is a member of the executive board for the International Society of Schema Therapy and holds the position of Training Co-Ordinator; she is also a member of the Group Certification Committee and the Training and Certification Advisory Board for Schema Therapy.
Dr Younan is a clinical supervisor/teacher for Australian Catholic University at the Post-Graduate level and a research consultant with a number of tertiary institutions studying the effectiveness of Schema Therapy across various clinical applications.
Dr Tamara May is a psychologist, established independent researcher and lecturer. Her research interests include advancing knowledge about autism, attention deficit hyperactivity disorder, other neurodevelopmental disorders and mental health problems including complex trauma and depression. Tamara has over 60 peer reviewed journal articles, has attracted over $2.5m in research funding and presented at over 30 international and national conferences. She is passionate about the assessment and treatment of young people and adults with neurodevelopmental and other chronic mental health problems using comprehensive approaches such as schema therapy.
CANCELLATION POLICY: No cancellation is possible once registered. Access to all sessions will be available after the summit ends to registered participants. For questions, please contact the ISST Office at: OFFICE
Are you an ISST Member? Enjoy deep discounts on tickets for the 2021 ISST Virtual Summit.
New York, USA
©2021 International Society of Schema Therapy e.V.
International Society of Schema Therapy e.V. is a not-for-profit organization. Glossop-Ring 35, DE-61118 Bad Vilbel, Germany
Why Schema Therapy?
Schema therapy has been extensively researched to effectively treat a wide variety of typically treatment resistant conditions, including Borderline Personality Disorder and Narcissistic Personality Disorder. Read our summary of the latest research comparing the dramatic results of schema therapy compared to other standard models of psychotherapy.